TITLE

HCV and HIV Counseling and Testing Integration in California: An Innovative Approach to Increase HIV Counseling and Testing Rates

AUTHOR(S)
Stopka, Thomas J.; Marshall, Clark; Bluthenthal, Ricky N.; Webb, David S.; Truax, Steven R.
PUB. DATE
May 2007
SOURCE
Public Health Reports;May/Jun2007 Supplement, Vol. 122, p68
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objectives. In California, injection drug users (IDUs) comprise the second leading risk group for human immunodeficiency virus (HIV) infection and the majority of hepatitis C virus (HCV) cases. Innovative disease screening and prevention activities are needed to improve disease surveillance and to guide appropriate public health responses. This study tested the hypothesis that offering HIV counseling and testing (C&T) concurrently with HCV C&T will increase HIV C&T rates among IDUs. Methods. From February through June 2003, HIV and HCV C&T were integrated in five California local health jurisdictions. HIV C&T and disclosure rates among IDUs were monitored when HIV C&T was offered alone during a baseline phase and when offered with HCV C&T during an intervention phase. Results. Among IDUs, HIV C&T rates were significantly higher when HIV and HCV C&T were offered together (27.1%, 354/1,305) than when HIV C&T services were offered alone (8.4%, 138/1,645) (p<0.05). HIV disclosure rates increased from 54.3% (75/138) when only HIV test results were disclosed to 71.8% (254/354) when HIV test results were disclosed concurrently with HCV test results (p<0.05). HCV prevalence among IDUs tested ranged from 23% to 75% at the five project sites. Integrating HIV and HCV C&T increased overall C&T time required for staff and clients and increased stress among counselors due to the number of positive test results (HCV) given to clients. Conclusions. Study results suggest that integrating HIV and HCV C&T can increase disease screening rates among IDUs. Careful planning of integrated staff activities and schedules is recommended.
ACCESSION #
24833649

 

Related Articles

  • Neuropsychiatric Complications of Injection-Associated Diseases: HIV and Hepatitis C. Rado, Jeffrey // Psychiatric Annals;Jan2017, Vol. 47 Issue 1, p38 

    Intravenous use of illicit substances increases the risk for transmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV). Both of these infections develop into chronic medical conditions with high morbidity and mortality. HIV and HCV may lead to significant neuropsychiatric...

  • Prevalence of hepatitis C virus and HIV infection among injection drug users in two Mexican cities bordering the U.S. White, Emily Faye; Garfein, Richard S.; Brouwer, Kimberly C.; Lozada, Remedios; Ramos, Rebeca; Firestone-Cruz, Michelle; Pérez, Saida G.; Magis-Rodríguez, Carlos; Conde-Glez, Carlos J.; Strathdee, Steffanie A. // Salud Pública de México;may/jun2007, Vol. 49 Issue 3, p165 

    Objective. To estimate the prevalence of the hepatitis C virus (HCV) and HIV infection and associated risk behaviors among injection drug users (IDUs) in two northern Mexican cities. Material and Methods. Between February and April 2005, IDUs were recruited in Tijuana (N=222) and Ciudad Juarez...

  • Harm reduction approach in Egypt: the insight of injecting drug users. Oraby, Doaa // Harm Reduction Journal;2013, Vol. 10 Issue 1, p1 

    Background: Egypt has low HIV prevalence (below 0.02%) among the general population, mostly attributed to the conservative culture. The 2010 second round biological/behavioral surveillance survey (Bio-BSS) conducted in some governorates revealed concentrated epidemic among male injecting drug...

  • High rate of seronegative HCV infection in HIV-positive patients. JUNIASTUTI; TAKAKO UTSUMI; NASRONUDIN; ALIMSARDJONO, LINDAWATI; AMIN, MOCHAMAD; ADIANTI, MYRNA; YOSHIHIKO YANO; SOETJIPTO; YOSHITAKE HAYASHI; HAK HOTTA; LUSIDA, MARIA INGE // Biomedical Reports;2014, Vol. 2 Issue 1, p79 

    Co-infection with human immunodeficiency virus (HIV) and hepatitis C virus (HCV) is a significant global health problem. The two viruses are transmitted with high efficacy via blood-to-blood contact, mainly intravenous drug use (IVDU), whereas HCV is less easily transmitted sexually. Antibody...

  • Parvovirus 4 Infection and Clinical Outcome in High-Risk Populations. Simmons, Ruth; Sharp, Colin; McClure, C. Patrick; Rohrbach, Janine; Kovari, Helen; Frangou, Eleni; Simmonds, Peter; Irving, Will; Rauch, Andri; Bowness, Paul; Klenerman, Paul // Journal of Infectious Diseases;Jun2012, Vol. 205 Issue 12, p1816 

    Parvovirus 4 (PARV4) is a DNA virus frequently associated with human immunodeficiency virus (HIV) and hepatitis C virus (HCV) infections, but its clinical significance is unknown. We studied the prevalence of PARV4 antibodies in 2 cohorts of HIV- and HCV-infected individuals (n = 469) and the...

  • Systematic review of HIV and HCV infection among drug users in China. Bao, Y.-P.; Liu, Z.-M. // International Journal of STD & AIDS;Jun2009, Vol. 20 Issue 6, p399 

    To determine the HIV and hepatitis C virus (HCV) geographical distribution among drug users in China, a systematic literature review of 40 peer-reviewed publications (comprising 15,565 drug users) was conducted. Of the total drug users, 10,724 were found to be injection drug users (IDUs) and...

  • Factors Associated With Prevalent Hepatitis C: Differences Among Young Adult Injection Drug Users in Lower and Upper Manhattan, New York City. Diaz, Theresa; Des Jarlais, Don C.; Vlahov, David; Perlis, Theresa E.; Edwards, Vincent; Friedman, Samuel R.; Rockwell, Russell; Hoover, Donald; Williams, Ian T.; Monterroso, Edgar R. // American Journal of Public Health;Jan2001, Vol. 91 Issue 1, p23 

    Conclusions. Several differences in factors associated with prevalent HCV infection existed among 2 populations of young injection drug users from the same city. Indirect transmission of HCV may occur. (Am J Public Health. 2001; 91:23-30)

  • Seroprevalence of Hepatitis B, Hepatitis C and Human Immunodeficiency viruses amongst Injecting Drug Users in Mumbai, India. SHUKLA, AVANTIKA; SHARMA, ANURADHA // Journal of Clinical & Diagnostic Research;Jun2014, Vol. 8 Issue 6, p1 

    The article presents a study on the seroprevalence of hepatitis B and C and human immunodeficiency viruses amongst injecting drug users (IDUs) in Mumbai, India. The study was conducted between August 2007 to October 2007. The study found less common causes of the viruses including household...

  • Attribution of Hepatitis C Virus Seroconversion Risk in Young Injection Drug Users in 5 US Cities. Hagan, Holly; Pouget, Enrique R.; Williams, Ian T.; Garfein, Richard L.; Strathdee, Steffanie A.; Hudson, Sharon M.; Latka, Mary H.; Ouellet, Lawrence J. // Journal of Infectious Diseases;2/1/2010, Vol. 201 Issue 3, p378 

    Background. In studies of hepatitis C virus (HCV) seroconversion in injection drug users (IDUs), some have questioned whether underreporting of syringe sharing, a stigmatized behavior, has led to misattribution of HCV risk to other injection-related behaviors. Methods. IDUs aged 15-30 years who...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics